Key Metrics
4.6
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
< 5
Impact Factor
Impact Factor
Impact factor of a journal is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years.
52
H index
H-Index
Journal's h-index reflects the collective citation impact of the authors publishing in the journal. The h-index is defined as the maximum value of h such that the given journal has published at least h papers that have each been cited at least h times.
Q2
Pharmacology
SJR
- Q2 Pharmacology
- Q2 Pharmacology (medical)
- Q2 Medicine (miscellaneous)
- Q2 Cardiology and Cardiovascular Medicine
SJR
SJR
SCImago Journal Rank measures weighted citations received by the serial. Citation weighting depends on subject field and prestige (SJR) of the citing serial.
0.87
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
6 Mo
Time to Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time To Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
% of papers by time taken from submission to publication
0 to 3 months
14%
4 to 6 months
36%
7 to 9 months
43%
Above 9 months
7%
Did you find this useful?
Thank you for your feedback.
Indexed in the following public directories
-
Web of Science -
Scopus -
DOAJ -
SJR
Topics Covered
- Blood pressure
- Genetic model
- Myocardial infarction
- Odds ratio
- Atrial fibrillation
- Heart rate
- Key genes
- Heart failure
- Red yeast rice
- Quality of life
- Placebo
- Clopidogrel
- Pulmonary hemodynamics
- Warfarin
- Hub genes
- Percutaneous coronary intervention
- Nutraceutical
- Catheter ablation
- Heat shock protein
- Rosuvastatin
Journal Specifications
| Overview | |
| Publisher | WILEY-HINDAWI |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | USD 2000 |
| Publication Time | 19 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Continuous publication |
| Publication Start Year | 2008 |
| Website URL | Visit website |
| Publication Details | |
| Other charges | Visit website |
| Plagiarism | Visit website |
| Waiver Policy | Visit website |
| Publication Time | 19 |
| Article Processing Charges | USD 2000 |
| Editorial Review Detail | |
| Editorial Team | Visit website |
| Review Process | Anonymous peer review |
| Review Url | Visit website |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY |
| OA statement | Visit website |
Planning to publish in Cardiovascular Therapeutics ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
Transcatheter Embolization in Congenital Cardiovascular Malformations—Variable Use of Vascular Plugs
- 29 May 24
- Cardiovascular Therapeutics
-
Full paper
Invasive Hemodynamic Changes Associated With Sodium-Glucose Cotransporter-2 Inhibitors: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
- 27 May 24
- Cardiovascular Therapeutics
-
Full paper
Attenuating Atherosclerosis through Inhibition of the NF-κB/NLRP3/IL-1β Pathway-Mediated Pyroptosis in Vascular Smooth Muscle Cells (VSMCs)
- 25 Mar 24
- Cardiovascular Therapeutics
-
Full paper
Perioperative Treatment with Rivaroxaban and Dabigatran on Changes of Coagulation and Platelet Activation Biomarkers following Left Atrial Appendage Closure.
- 12 Mar 24
- Cardiovascular therapeutics
-
Full paper
DUSP22 Ameliorates Endothelial-to-Mesenchymal Transition in HUVECs through Smad2/3 and MAPK Signaling Pathways.
- 8 Mar 24
- Cardiovascular therapeutics
-
Full paper
Major Limitations of Cardiovascular Risk Scores.
- 28 Feb 24
- Cardiovascular therapeutics
Scite analysis
Powered by scite_
1k articles received 14.7k citations see all
- 551 Supporting
- 13,496 Mentioning
- 75 Contrasting
Editorial notices
- 0 Retractions
- 0 Withdrawals
- 1 Corrections
- 2 Errata
- 0 Expression of Concern
FAQs
How long has Cardiovascular Therapeutics been actively publishing?
Cardiovascular Therapeutics has been in operation since 2008 till date.
What is the publishing frequency of Cardiovascular Therapeutics ?
Cardiovascular Therapeutics published with a Continuous publication frequency.
How many articles did Cardiovascular Therapeutics publish last years ?
In 2023, Cardiovascular Therapeutics published 34 articles.
What is the eISSN & pISSN for Cardiovascular Therapeutics ?
For Cardiovascular Therapeutics,eISSN is 1755-5922 and pISSN is1755-5914.
What is Citescore for Cardiovascular Therapeutics ?
Citescore for Cardiovascular Therapeutics is 4.6.
What is H index for Cardiovascular Therapeutics ?
H index for Cardiovascular Therapeutics is 52.
What is SNIP score for Cardiovascular Therapeutics ?
SNIP score for Cardiovascular Therapeutics is 0.87.
What is the SJR for Cardiovascular Therapeutics ?
SJR for Cardiovascular Therapeutics is Q2.
Who is the publisher of Cardiovascular Therapeutics ?
WILEY-HINDAWI is the publisher of Cardiovascular Therapeutics.